These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4588285)

  • 1. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.
    Kaegi A; Pineo GF; Shimizu A; Trivedi H; Hirsh J; Gent M
    N Engl J Med; 1974 Feb; 290(6):304-6. PubMed ID: 4588285
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.
    Kaegi A; Pineo GF; Shimizu A; Trivedi H; Hirsh J; Gent M
    Circulation; 1975 Sep; 52(3):497-9. PubMed ID: 1098808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of thrombosis of the arteriovenous shunts used for hemodialysis].
    Mal'kov PS; Aliev RA
    Urol Nefrol (Mosk); 1974; (6):41-4. PubMed ID: 4446186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
    Köhler H
    Klin Wochenschr; 1977 Jan; 55(2):49-56. PubMed ID: 834017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal blood loss in patients undergoing maintenance dialysis.
    Wizemann V; Buddensiek P; de Boor J; Grebe S; Schütterle G
    Kidney Int Suppl; 1983 Dec; 16():S218-20. PubMed ID: 6588252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulant treatment for avoiding the shunt-induced thrombosis in patients on hemodialysis].
    Köstering H; Walther C; Quellhorst E; Wigger W; Scheler F
    Med Klin; 1970 Nov; 65(46):2012-8. PubMed ID: 5521076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Certain complications caused by the use of external arteriovenous shunt and internal arteriovenous fistula in patients with terminal renal insufficiency kept on regular hemodialysis].
    Ermolenko VM; Polevikov VV
    Sov Med; 1974 Nov; (11):72-7. PubMed ID: 4612749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Valenta J; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):673-80. PubMed ID: 3526712
    [No Abstract]   [Full Text] [Related]  

  • 11. [The drug prevention of thrombotic complications of the vascular approach--arteriovenous fistulae and synthetic prostheses in patients on hemodialysis with antistenocardin].
    Kraev Z; Baldev TS
    Khirurgiia (Sofiia); 1990; 43(5):53-6. PubMed ID: 2102939
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 13. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 14. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early subacute complications from arteriovenous fistulas in extracorporeal hemodialysis].
    Bachleda P; Utíkal P; Zadrazil J; Grosmanová T
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():67-8. PubMed ID: 1344604
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin.
    Harter HR; Burch JW; Majerus PW; Stanford N; Delmez JA; Anderson CB; Weerts CA
    N Engl J Med; 1979 Sep; 301(11):577-9. PubMed ID: 112475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of thrombolytic preparations for the functional restoration of the arteriovenous fistula in patients on programmed hemodialysis].
    Sukhanov VA; Nazarov AV; Zlokazov VB; Chuzhinov SV
    Ter Arkh; 1989; 61(12):89-91. PubMed ID: 2629155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of the Doppler method of blood flow measurement in prevention of thrombosis of surgical arteriovenous shunts for periodical hemodialysis. Preliminary study].
    Simoni GA; Viacava A; Gori A; Bonalumi U; Adami G; Gianetta E; Altomonte F; Griffanti-Bartoli F
    Minerva Cardioangiol; 1982 Nov; 30(11):605-8. PubMed ID: 7155366
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.
    Domoto DT; Bauman JE; Joist JH
    Thromb Res; 1991 Jun; 62(6):737-43. PubMed ID: 1926064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.